Arcinova Q3 Newsletter 2016
We are proud to present our first quarterly newsletter, with important updates including the progression of our API development capabilities and the addition of GC-MS to broaden the scope of our offerings to our customers.
Discover how Arcinova can help
We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.
